Mobile

A study to learn how hereditary and sporadic thyroid cancer patients, treated with ZD6474 react to the drug, what happens to ZD6474 in the human body, about the side effects of ZD6474 and if ZD6474 ca...

Mise à jour : Il y a 5 ans
Référence : EUCTR2005-005077-29

A study to learn how hereditary and sporadic thyroid cancer patients, treated with ZD6474 react to the drug, what happens to ZD6474 in the human body, about the side effects of ZD6474 and if ZD6474 can decrease or prevent tumour growth

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate an improvement in progression-free survival (PFS) with ZD6474 as compared to placebo in subjects with unresectable locally advanced or metastatic MTC

Critère d'inclusion

  • Medullary Thyroid Cancer

Liens